Literature DB >> 15943627

Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients.

Michael B Ishitani1, Dawn S Milliner, Dean Y Kim, Humberto E Bohorquez, Julie K Heimbach, Patrick F Sheedy, Bruce Z Morgenstern, James M Gloor, Joseph G Murphy, Robert D McBane, Lawrence F Bielak, Patricia A Peyser, Mark D Stegall.   

Abstract

Coronary artery disease (CAD) is the leading cause of death in adults after successful kidney transplantation. Children who have undergone successful kidney transplantation are entering young adulthood; however, the prevalence and extent of CAD in this population is unknown. We conducted a pilot study in young adults with stable allograft function, who received kidney transplants as children to measure coronary artery calcification (CAC), a marker of coronary artery atherosclerosis and CAD. We evaluated 19 young adults after successful pediatric kidney transplantation for known CAD risk factors; these patients underwent noninvasive imaging with electron-beam computed tomography (EBCT) for measurement of CAC. Prevalence and quantity of CAC were then compared to asymptomatic individuals from the community. All patients had multiple risk factors for CAD. Mean age at evaluation was 32 years (range: 21-48 years). CAC is uncommon in individuals in the community in this age range; however, nearly half of our patients had CAC detected with the quantity of CAC comparable to asymptomatic individuals from the community 10-40 years older. These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15943627     DOI: 10.1111/j.1600-6143.2005.00914.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 2.  Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.

Authors:  Nadine Khouzam; Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2017-09-22       Impact factor: 3.714

3.  Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function.

Authors:  Dagmar-Christiane Fischer; Claudia Jensen; Anja Rahn; Birgit Salewski; Günther Kundt; Geert J Behets; Patrick D'Haese; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2010-10-15       Impact factor: 3.714

Review 4.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 5.  The role of bone in CKD-mediated mineral and vascular disease.

Authors:  Nadine M Khouzam; Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2014-08-29       Impact factor: 3.714

Review 6.  Cardiovascular risk factors in children on dialysis: an update.

Authors:  Uwe Querfeld; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2018-10-31       Impact factor: 3.714

Review 7.  CKD-MBD after kidney transplantation.

Authors:  Katherine Wesseling-Perry; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2011-03-11       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.